Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals submits copy of press release

05 Dec 2016 Evaluate

Alembic Pharmaceuticals has submitted a copy of Press Release dated December 05, 2016 titled ‘Alembic Pharmaceuticals receives USFDA Approval for Zolmitriptan Orally Disintegrating Tablets.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..